Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Emerging-Markets Bond · MFS

MEDIX Expense Ratio & Fees

Ticker MEDIX · · Holdings as of Jul 31, 2026

Expense ratio
0.82%$82/yr per $10k
5-yr return
+1.2%annualized
1-yr return
+7.1%as of Dec 2024
Net assets
$7.5Ball share classes
Holdings
504

Bottom line

What is MEDIX's expense ratio?

MEDIX's expense ratio is 0.82%, or about $82 a year on every $10,000 invested. That is cheaper than 65% of emerging-markets bond funds we track (median 0.92%). It has no front-end sales load.

Updated Nov 26, 2025

MEDIX fee table

Net expense ratio0.82%
Gross expense ratio0.83%
Management fee0.67%
12b-1 (distribution) fee0%
Other expenses0.16%
Fee waiver / reimbursement-0.01%
Max front-end sales load0%
Max deferred sales charge0%

Source: Fund prospectus fee table, filed Nov 26, 2025

What MEDIX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
MEDIX$84$264$460$1,024

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 0.82% expense ratio costs roughly $46,100 in lost growth, versus about $51,300 for the median emerging-markets bond fund (0.92%).

Cheapest way to own MFS Emerging Markets Debt Fund

All share classes
TickerClassExpense ratioFront load
MEDHXR60.71%0%
MEDGXR40.82%0%
MEDIXI0.82%0%
MEDAXA1.07%4.25%
MEDFXR31.07%0%
MEDEXR21.32%0%
MEDCXC1.82%0%
MEDDXR11.82%0%
MEDBXB1.82%0%